shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Dec 3rd - Collaborative and Proactive Solutions at School: Moving from power and control to collaboration and problem solving [SickKids CCMH Learning Institute]
Dec 11th - ONTABA 2020 Annual Conference [ONTABA - Ontario Association for Behaviour Analysis]
May 1st - American Psychiatric Association 174th annual meeting, Los Angeles [APA]
Jun 17th - IARPP Conference 2021 - Expanding Our Clinical Experiences: The Spoken, Unspoken and Unspeakable in Relational Psychoanalysis and Psychotherapy [IARPP]
Jul 9th - 28th Annual OCD Conference [International OCD Foundation]
schools agencies and other institutional orders (click here)
Due to Covid-19, we are now open only for deliveries and pickups. Still free shipping across Canada for orders over $50. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Before Prozac : The Troubled History of Mood Disorders in Psychiatry
Shorter, Edward, PhD
Oxford University Press / Hardcover / 2008-11-01 / 0195368746
Psychiatry / Social & Political Issues
price: $33.95 (may be subject to change)
336 pages
Not in Stock, usually ships in 7-10 business days

Psychiatry today is a barren tundra, writes medical historian Edward Shorter, where drugs that don't work are used to treat diseases that don't exist. In this provocative volume, Shorter illuminates this dismal landscape, in a revealing account of why psychiatry is "losing ground" in the struggle to treat depression.

Naturally, the book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: the FDA, the very agency charged with ensuring drug safety and effectiveness. Shorter describes how the FDA permits companies to test new products only against placebo. If you can beat sugar pills, you get your drug licensed, whether or not it is actually better than (or even as good as) current medications, thus sweeping from the shelves drugs that may be superior but have lost patent protection.

The book also examines the FDA's early power struggles against the drug industry, an influence-grab that had little to do with science, and which left barbiturates, opiates, and amphetamines all underprescribed, despite the fact that under careful supervision they are better at treating depression, with fewer side effects, than the newer drugs in the Prozac family. Shorter also castigates academia, showing how two forms of depression, melancholia and nonmelancholia--"as different from each other as chalk and cheese"--became squeezed into one dubious classification, major depression, which was essentially a political artifact born of academic infighting.

An astonishing and troubling look at modernpsychiatry, Losing Ground is a book that is sure to spark controversy for years to come.

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / 12-5 Sun (EST)

search
Click here to read previous issues.
authors
Shorter, Edward
other lists
Canadian Authors
Canadian Authors in Psychoanalysis
Featured OUP Titles - AG
Oxford U Press - Trade Titles
Oxford University Press
Psychiatry
Social & Political Issues
Toronto Authors
U of T Dept Psychiatry Authors
University Presses